期刊文献+

尿苷二磷酸葡醛酸转移酶的研究进展 被引量:1

Progress of UDP-glucuronosyltransferases
下载PDF
导出
摘要 尿苷二磷酸葡醛酸转移酶(UGT)是体内最重要的Ⅱ相代谢酶,它可以参与许多内源性物质如胆红素、甾体激素、甲状腺激素、胆汁酸和脂溶性维生素等的代谢,在许多药物如阿片类药物、镇痛药、非甾体抗炎药和抗惊厥药等的代谢中也发挥着重要的作用。UGT在药物的吸收、分布、代谢和排泄中发挥重要作用。研究UGT特别是其基因多态性及其介导的药物-药物相互作用不仅可以指导临床用药,也可以揭示内源性物质代谢紊乱的机制。本文就UGT的分类、组织分布、对药物吸收的影响、基因多态性及其所介导的药物-药物相互作用进行综述。 UDP-giucuronosyltransferases (UGT) are the most important phase II drug metabolizing enzyme, which can metabolize not only various endogenous substances, such as bUirubin, steroid hormones, thyroid hormones, bile acids and fat-soluble vitamins, but also many drugs, such as opioids, analgesics, NSAID and anticonvulsants. UGT plays an important role in drug absorbtion, metabolism, distribution and excretion. Furthermore, the inhibition or induction of UGT could not only result in serious drug-drug interactions, but also induce metabolic disorders of endogenous sub- stances, for which evaluation of the inhibitory or induction effects of compounds on UGT is very important in clinic. This paper reviewed UGT in terms of its classification, tissue distribution, effect on drug absorption, gene polymorphism and related drug-drug interactions.
作者 崔冬雪
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2013年第1期123-126,共4页 Chinese Journal of Pharmacology and Toxicology
关键词 尿苷二磷酸葡醛酸 转移酶类 药物相互作用 多态性 单核苷酸 uridine diphosphate glucuronic acid transferases drug interactions polymorphism, single nucleotide
  • 相关文献

参考文献32

  • 1King CD, Rios GR, Green MD, Tephly TR. UDP-glucuronosyl- transfemses[ J]. Curr Drug Metab, 2000, 1 (2) :143-161.
  • 2Fisher MB, Paine MF, Strelevitz T J, Wrighton SA. The role of he- patic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism[J].Drug Metab Rev, 2001,33(3-4) :273-297.
  • 3Evans WE, Relling MV. Pharmacogenomics: translating function- al genomics into rational therapeutics [J ]. Science, 1999, 286 (5439) :487-491.
  • 4Burchell B, Ebner T, Wooster W, etal. The UDP-glucuronosyl- transferase gene family= Function and expression of human UGTs [J]. J Basic Clin Physiol Pharmacol, 2011,3(Suppl) :22.
  • 5Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, lyana- gi T, etal. Nomenclature update for the mammalian UDP glycosyl- transferase (UGT) gene superfamily[J]. Pharmacogenet Genomics, 2005, 15(10) :677-685.
  • 6McGurk KA, Briedey CH, Burchell B. Drug glucuronidation by hu- man renal UDP-gl 1998, 55(7) :1005-1012.
  • 7Soars MG, Riley R J, Findlay KA, Coffey M J, Bumhell B. Evidence for significant differences in microsomal drug glucuronidation by ca- nine and human liver and kidne[J]. Drug Metab Dispos, 2001, 29(2) :121-126.
  • 8Ohno S, Nakajin S. Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in va- rious human tissues by real-time reverse transcriptase-polymerase chain reaction [ J ]. Drug Metab Dispos, 2009, 37 ( 1 ) :32-40.
  • 9Jedlitschky G, Cassidy A J, Sales M, Pratt N, Burchell B. Cloning and characterization of a novel human olfactory UDP-glucuronosyl- transferase [ J ]. Biochem J, 1999, 340 ( Pt 3 ) :837-843.
  • 10Kiang TK, Ensom MH, Chang TK. UDP-glucuronosyltransferases and clinical drug-drug interactions [ J ]. Pharmacol Ther, 2005, 106 (1) :97-132.

同被引文献8

  • 1Sun X,Lemyre B,Nan X,et al.Free thyroxine and thyroidstimulating hormone reference intervals in very low birth weight infants at 3-6 weeks of life with the Beckman Coulter Unicel Dxl 800[J].Clin Biochem,2014,47(1-2):16-18.
  • 2Visser TJ,Kaptein E,Glatt H,et al.Characterization of thyroid hormone sulfotransferases[J].Chem Biol Interact,1998,109(1-3):279-291.
  • 3Barter RA,Klaassen CD.Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDPglucuronosyltransferase inducers in rats[J].Toxicol Appl Pharmacol,1994,128(1):9-17.
  • 4Huang WS,Kuo SW,Chen WL,et al.Increased urinary excretion of sulfated 3,3',5-triiodothyronine in patients with nodular goiters receiving suppressive thyroxine therapy[J].Thyroid,1996,6(2):91-96.
  • 5Kelly GS.Peripheral metabolism of thyroid hormones:a review[J].Altern Med Rev,2000,5(4):306-333.
  • 6Malik R,Hodgson H.The relationship between the thyroid gland and the liver[J].QJM,2002,95(9):559-569.
  • 7蒋翔,江剑辉,李蓓,吴伽,陈倩瑜,曹伟锋,贾雪芳.209860例不同胎龄及出生体重新生儿先天性甲状腺功能减退症的筛查结果[J].中华围产医学杂志,2013,16(11):687-689. 被引量:21
  • 8郭红伟,段宇.多氯联苯对甲状腺的干扰作用[J].国际内分泌代谢杂志,2014,34(2):81-83. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部